BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30192394)

  • 1. Dietary Macronutrient Composition Determines the Contribution of DGAT1 to Alcoholic Steatosis.
    Huang LS; Yuen JJ; Trites MJ; Saha A; Epps CT; Hu Y; Kerolle S; Lee SA; Jiang H; Goldberg IJ; Blaner WS; Clugston RD
    Alcohol Clin Exp Res; 2018 Dec; 42(12):2298-2312. PubMed ID: 30192394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
    Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
    J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
    Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice.
    Lee B; Fast AM; Zhu J; Cheng JX; Buhman KK
    J Lipid Res; 2010 Jul; 51(7):1770-80. PubMed ID: 20147738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis.
    Clugston RD; Yuen JJ; Hu Y; Abumrad NA; Berk PD; Goldberg IJ; Blaner WS; Huang LS
    J Lipid Res; 2014 Feb; 55(2):239-46. PubMed ID: 24280415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
    Fengler VH; Macheiner T; Kessler SM; Czepukojc B; Gemperlein K; Müller R; Kiemer AK; Magnes C; Haybaeck J; Lackner C; Sargsyan K
    PLoS One; 2016; 11(5):e0155163. PubMed ID: 27167736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal acyl-CoA:diacylglycerol acyltransferase 2 overexpression enhances postprandial triglyceridemic response and exacerbates high fat diet-induced hepatic triacylglycerol storage.
    Uchida A; Slipchenko MN; Eustaquio T; Leary JF; Cheng JX; Buhman KK
    Biochim Biophys Acta; 2013 Aug; 1831(8):1377-85. PubMed ID: 23643496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids.
    Villanueva CJ; Monetti M; Shih M; Zhou P; Watkins SM; Bhanot S; Farese RV
    Hepatology; 2009 Aug; 50(2):434-42. PubMed ID: 19472314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice.
    Gluchowski NL; Gabriel KR; Chitraju C; Bronson RT; Mejhert N; Boland S; Wang K; Lai ZW; Farese RV; Walther TC
    Hepatology; 2019 Dec; 70(6):1972-1985. PubMed ID: 31081165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease.
    Wang Z; Yao T; Song Z
    J Lipid Res; 2010 Nov; 51(11):3158-65. PubMed ID: 20739640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
    Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
    Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The triglyceride synthesis enzymes DGAT1 and DGAT2 have distinct and overlapping functions in adipocytes.
    Chitraju C; Walther TC; Farese RV
    J Lipid Res; 2019 Jun; 60(6):1112-1120. PubMed ID: 30936184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Diacylglycerol Acyltransferase 2 Versus Diacylglycerol Acyltransferase 1: Potential Therapeutic Implications of Pharmacology.
    Amin NB; Saxena AR; Somayaji V; Dullea R
    Clin Ther; 2023 Jan; 45(1):55-70. PubMed ID: 36690550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
    Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
    Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DS-7250, a Diacylglycerol Acyltransferase 1 Inhibitor, Enhances Hepatic Steatosis in Zucker Fatty Rats via Upregulation of Fatty Acid Synthesis.
    Yasuno K; Kumagai K; Iguchi T; Tsuchiya Y; Kai K; Mori K
    Toxicol Pathol; 2018 Apr; 46(3):302-311. PubMed ID: 29587622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dgat1 and Dgat2 regulate enterocyte triacylglycerol distribution and alter proteins associated with cytoplasmic lipid droplets in response to dietary fat.
    Hung YH; Carreiro AL; Buhman KK
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jun; 1862(6):600-614. PubMed ID: 28249764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic overexpression of CTRP3 prevents alcohol-induced hepatic triglyceride accumulation.
    Trogen G; Bacon J; Li Y; Wright GL; Degroat A; Hagood KL; Warren Z; Forsman A; Kilaru A; Clark WA; Peterson JM
    Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E949-E960. PubMed ID: 29763374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1.
    Yamazaki T; Sasaki E; Kakinuma C; Yano T; Miura S; Ezaki O
    J Biol Chem; 2005 Jun; 280(22):21506-14. PubMed ID: 15797871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity.
    Yamamoto T; Yamaguchi H; Miki H; Kitamura S; Nakada Y; Aicher TD; Pratt SA; Kato K
    Eur J Pharmacol; 2011 Jan; 650(2-3):663-72. PubMed ID: 21034741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betaine attenuates chronic alcohol‑induced fatty liver by broadly regulating hepatic lipid metabolism.
    Yang W; Huang L; Gao J; Wen S; Tai Y; Chen M; Huang Z; Liu R; Tang C; Li J
    Mol Med Rep; 2017 Oct; 16(4):5225-5234. PubMed ID: 28849079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.